Atlas Trials

Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease

Clinical trial NCT00431249 · COMPLETED

Trial details

NCT number
NCT00431249
Sponsor
Tungs' Taichung Metroharbour Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hemodialysis PatientsPeripheral Vascular Disease
Start date
2007-02-01
Primary completion
2008-04-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.